Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches

Open access
Cheng, Xiaofei, Zhao, Feng, Ke, Bingxin, Chen, Dong, Liu, Fanlong · 2023 · Cancers

Abstract

Drug resistance remains a significant challenge in the treatment of colorectal cancer (CRC). In recent years, the emerging field of ferroptosis, a unique form of regulated cell death characterized by iron-dependent lipid peroxidation, has offered new insights and potential therapeutic strategies for overcoming drug resistance in CRC. This review examines the role of ferroptosis in CRC and its impact on drug resistance. It highlights the distinctive features and advantages of ferroptosis compared to other cell death pathways, such as apoptosis and necrosis. Furthermore, the review discusses current research advances in the field, including novel treatment approaches that target ferroptosis. These approaches involve the use of ferroptosis inducers, interventions in iron metabolism and lipid peroxidation, and combination therapies to enhance the efficacy of ferroptosis. The review also explores the potential of immunotherapy in modulating ferroptosis as a therapeutic strategy. Additionally, it evaluates the strengths and limitations of targeting ferroptosis, such as its selectivity, low side effects, and potential to overcome resistance, as well as challenges related to treatment specificity and drug development. Looking to the future, this review discusses the prospects of ferroptosis-based therapies in CRC, emphasizing the importance of further research to elucidate the interaction between ferroptosis and drug resistance. It proposes future directions for more effective treatment strategies, including the development of new therapeutic approaches, combination therapies, and integration with emerging fields such as precision medicine. In conclusion, harnessing ferroptosis represents a promising avenue for overcoming drug resistance in CRC. Continued research efforts in this field are crucial for optimizing therapeutic outcomes and providing hope for CRC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers15215209

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Classic signaling pathways of ferroptosis. Illustration depicting the fundamental signaling pathways associated with ferroptosis. The figure outlines the canonical GPX4-regulated pathway, focusing on the role of GPX4 in lipid peroxide reduction, the iron metabolism pathway elucidating the iron-dependent aspects of ferroptosis, and the lipid metabolism pathway highlighting lipid peroxidation and its contribution to cell membrane rupture. These interconnected pathways underscore the multifaceted nature of ferroptotic cell death. The figures were created using the Figdraw software (https://www.figdraw.com, accessed on 13 August 2023).
Figure 1 Classic signaling pathways of ferroptosis. Illustration depicting the fundamental signaling pathways associated with ferroptosis. The figure outlines the canonical GPX4-regulated pathway, focusing on the role of GPX4 in lipid peroxide reduction, the iron metabolism pathway elucidating the iron-dependent aspects of ferroptosis, and the lipid metabolism pathway highlighting lipid peroxidation and its contribution to cell membrane rupture. These interconnected pathways underscore the multifaceted nature of ferroptotic cell death. The figures were created using the Figdraw software (https://www.figdraw.com, accessed on 13 August 2023).CC BY · PubMed Central
Figure 2 Mechanisms of drug resistance reversal through ferroptosis targeting. This figure illustrates diverse molecular interactions and sites of action for various agents aimed at reversing drug resistance through ferroptosis modulation. In the diagram, red text denotes sites of action for agents targeting ferroptosis reversal in chemotherapy, blue text represents sites of action for agents targeting ferroptosis reversal specifically, and green text indicates sites of action for agents targeting ferroptosis reversal in immunotherapy. The integrated approach to targeting these pathways highlights their potential synergistic effects in overcoming drug resistance. The figures were created using the Figdraw software (https://www.figdraw.com, accessed on 13 August 2023).
Figure 2 Mechanisms of drug resistance reversal through ferroptosis targeting. This figure illustrates diverse molecular interactions and sites of action for various agents aimed at reversing drug resistance through ferroptosis modulation. In the diagram, red text denotes sites of action for agents targeting ferroptosis reversal in chemotherapy, blue text represents sites of action for agents targeting ferroptosis reversal specifically, and green text indicates sites of action for agents targeting ferroptosis reversal in immunotherapy. The integrated approach to targeting these pathways highlights their potential synergistic effects in overcoming drug resistance. The figures were created using the Figdraw software (https://www.figdraw.com, accessed on 13 August 2023).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 137 references

Cited by

See all 46

Metadata

Authors
Cheng, X., Zhao, F., Ke, B., Chen, D., & Liu, F.
Affiliations
First Affiliated Hospital Zhejiang University (CN)
Corresponding author
  • Cheng, Xiaofei
  • Liu, Fanlong
Venue
Cancers
Publisher
MDPI AG
Published
2023-10-30
Volume
15
Issue
21
Pages
5209
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4388017931
Cited by
44
References
137
Citations by year
2026: 12 · 2025: 20 · 2024: 12
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
ferroptosis, colorectal cancer, drug resistance, iron metabolism, lipid peroxidation, ferroptosis inducers, combination therapy, immunotherapy, targeted therapy, precision medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. https://app.cochat.ai/papers/10.3390/cancers15215209
The paper
Cheng, X., Zhao, F., Ke, B., Chen, D., & Liu, F. (2023). Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. Cancers. https://doi.org/10.3390/cancers15215209

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.